Back to Authors

Mao, Fangya

https://orcid.org/0000-0003-1162-4348

Mayo Clinic

Canadian Cancer Trials Group

Citations 1

CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).
Parulekar, Wendy R. , Shepherd, Lois E. , Virk, Shakeel , Ennis, Marguerite , Mao, Fangya , Ligibel, Jennifer A. , Rastogi, Priya , Hobday, Timothy J. , Thompson, Alastair M. , Rabaglio, Manuela , Whelan, Timothy J. , Ennis, Marguerite , Rabaglio-Poretti, Manuela , Dowling, Ryan J.O. , Gelmon, Karen A. , Hershman, Dawn L. , Mayer, Ingrid A. , Lemieux, Julie , Stambolic, Vuk , Chen, Bingshu E. , Goodwin, Pamela J.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 557-557

10.1200/jco.2018.36.15_suppl.557 Get It